Literature DB >> 24423706

Malaria in developing countries.

Gema Ruíz López Del Prado1, Cristina Hernán García, Lourdes Moreno Cea, Virginia Fernández Espinilla, Ma Fe Muñoz Moreno, Antonio Delgado Márquez, Ma José Polo Polo, Irene Andrés García.   

Abstract

Malaria still poses a real threat to travellers, particularly in areas with high transmission rates such as sub-Saharan Africa, Papua New Guinea, and the South Pacific islands. Malaria causes an estimated 660,000 deaths each year from 219 million cases of illness. It is a preventable and curable disease. Malaria symptoms appear after a period of seven days or longer, and without treatment, the disease can lead to death. Mosquito bite prevention is the main way to reduce malaria transmission. Chemoprophylaxis recommendations depend on travelers' age, destination, type of travelling, or length of stay. Pregnant women, children, and immunosuppressed travelers are the most susceptible. There are currently no licensed vaccines against malaria. Results about a research vaccine candidate known as RTS,S/AS01 are expected in 2015.

Entities:  

Mesh:

Year:  2014        PMID: 24423706     DOI: 10.3855/jidc.4610

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  7 in total

Review 1.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

2.  Primary care challenges of an obscure case of "Alice in Wonderland" syndrome in a patient with severe malaria in a resource-constrained setting: a case report.

Authors:  Benjamin Momo Kadia; Cyril Jabea Ekabe; Ettamba Agborndip
Journal:  BMC Infect Dis       Date:  2017-12-22       Impact factor: 3.090

3.  Patterns and trends of malaria in 25 risk districts of Nepal from 2001 to 2017.

Authors:  Nirmal Gautam; Sampurna Kakchapati; Sarala Shrestha; Wandee Wanishsakpong
Journal:  Clin Exp Vaccine Res       Date:  2019-01-31

4.  Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations.

Authors:  Omkar Indari; Budhadev Baral; Kartik Muduli; Ambika Prasad Mohanty; Natabar Swain; Nirmal Kumar Mohakud; Hem Chandra Jha
Journal:  Biosaf Health       Date:  2021-04-30

5.  Differences in malaria and haematocrit presentation in children living in different settings, North West Region, Cameroon.

Authors:  Ebanga Echi J Eyong; Hyloson Nkwengang; Laurentine Sumo
Journal:  Malariaworld J       Date:  2021-06-01

6.  Significant Decline of Malaria Incidence in Southwest of Iran (2001-2014).

Authors:  Shokrollah Salmanzadeh; Masoud Foroutan-Rad; Shahram Khademvatan; Sasan Moogahi; Shahla Bigdeli
Journal:  J Trop Med       Date:  2015-11-16

7.  Inhibition of Plasmodium sporogonic stages by ivermectin and other avermectins.

Authors:  Raquel Azevedo; António M Mendes; Miguel Prudêncio
Journal:  Parasit Vectors       Date:  2019-11-21       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.